Identifying a chronic health condition listed on CMS WEBSITE:       *PMHNP students should select a population focused chronic condition (i.e.,

  1. Identifying a chronic health condition listed on CMS WEBSITE:       *PMHNP students should select a population focused chronic condition (i.e., Depression, Schizophrenia, Psychotic Disorders, etc. from this list).
  2. Description of the health issue chosen from the CMS website.
  3. The incidence and prevalence of this condition in the US.
  4. How the condition is diagnosed, monitored, and treated in individuals with this condition?
  5. Description of the interdisciplinary team that will participate in coordinating care. Specifically, define the role of the APRN in management and coordination.  
  6. Can care teams use the CCCR model? Think in terms of systems and complexity reflective thinking. If not, name another model to help manage care?
  7. What is the cost of managing this disease in the county you live? 
  8. What resources are available to help manage the costs of care related to this condition?
  9. Identify barriers or challenges that you foresee for patients and care teams. How can barriers be overcome?

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial

  Read “M2 Dimick Sorting out Advance Directives_Journal of AHIMA HL.pdf” attached above. You are a Medical Records Technician at Northwestern Memorial Hospital.  One of your tasks is applying applicable laws, policies, and procedures for ROI. For each scenario, describe the decision you render.  Answer the two questions that follow.

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in

As a psychiatric mental health nurse practitioner (PMHNP), how do you approach the management of treatment-resistant schizophrenia, particularly in cases where traditional antipsychotic medications and psychosocial interventions have been ineffective? What are the challenges and opportunities in utilizing biomarkers of inflammation to aid in the early diagnosis and personalized treatment